About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Cdkn1a
cyclin dependent kinase inhibitor 1A
MGI:104556
102 phenotypes from 6 alleles in 14 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Cdkn1atm1.1(KOMP)Vlcg/Cdkn1atm1.1(KOMP)Vlcg
C57BL/6N-Cdkn1atm1.1(KOMP)Vlcg/Ucd 		abnormal epididymis morphology J:211773
abnormal spleen morphology J:211773
abnormal testis morphology J:211773
enlarged epididymis J:211773
enlarged spleen J:211773
small testis J:211773
Cdkn1atm1Hpw/Cdkn1atm1Hpw
involves: 129X1/SvJ 		normal growth/size/body region phenotype J:199432
normal homeostasis/metabolism phenotype J:199432
Cdkn1atm1Led/Cdkn1a+
involves: 129S6/SvEvTac 		abnormal auchene hair morphology J:125208
abnormal awl hair morphology J:125208
decreased zigzag hair amount J:125208
Cdkn1atm1Led/Cdkn1atm1Led
involves: 129S6/SvEvTac 		abnormal auchene hair morphology J:125208
abnormal awl hair morphology J:125208
abnormal cell cycle checkpoint function J:57882
abnormal chromosome number J:57882
decreased zigzag hair amount J:125208
increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
increased fibroblast proliferation J:57882
increased T cell proliferation J:76041
premature death J:76041
Cdkn1atm1Led/Cdkn1atm1Led
involves: 129S6/SvEvTac * NIH Black Swiss 		abnormal cell cycle J:28420
Cdkn1atm1Led/Cdkn1atm1Led
NIH.Cg-Cdkn1atm1Led 		abnormal tumor incidence J:87536
decreased lymphoma incidence J:87536
Cdkn1atm1Led/Cdkn1atm1Led
Tg(Upk2-cre)6Xrw/0
involves: 129S6/SvEvTac * FVB/N 		normal neoplasm J:234236
Cdkn1atm1Tyj/Cdkn1a+
involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J 		increased incidence of tumors by ionizing radiation induction J:83967
increased malignant tumor incidence J:83967
Cdkn1atm1Tyj/Cdkn1atm1Tyj
B6;129S2-Cdkn1atm1Tyj/J 		abnormal bone marrow cell morphology/development J:108569
normal cardiovascular system phenotype J:216295
decreased monocyte cell number J:108569
decreased susceptibility to induced arthritis J:108569
normal hearing/vestibular/ear phenotype J:98518
impaired macrophage chemotaxis J:108569
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129/Sv * 129S2/SvPas * C57BL/6 		abnormal cell physiology J:72780
abnormal keratinocyte physiology J:72780
abnormal skin physiology J:72780
delayed cellular replicative senescence J:72780
increased squamous cell carcinoma incidence J:72780
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 		normal cardiovascular system phenotype J:216295
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J 		increased incidence of tumors by ionizing radiation induction J:83967
increased malignant tumor incidence J:83967
increased metastatic potential J:83967
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129S2/SvPas 		abnormal hematopoietic stem cell physiology J:60945
abnormal junctional epithelium morphology J:102001
abnormal neuronal precursor proliferation J:90479
abnormal prostate gland dorsolateral lobe morphology J:115443
abnormal response to CNS ischemic injury J:90479
decreased body weight J:102001
decreased physiological sensitivity to xenobiotic J:59647
decreased prostate gland dorsolateral lobe weight J:115443
decreased seminal vesicle weight J:115443
increased body weight J:118516
increased brain weight J:118516
increased brown adipose tissue amount J:118516
increased cell proliferation J:180692
increased cellular sensitivity to ultraviolet irradiation J:85569
increased circulating cholesterol level J:118516
increased DNA replication J:59647
increased hematopoietic stem cell number J:60945
increased inguinal fat pad weight J:118516
increased kidney weight J:118516
increased neuron number J:90479
increased neuronal precursor cell number J:90479
increased parametrial fat pad weight J:118516
increased sensitivity to induced cell death J:85569
increased susceptibility to induced morbidity/mortality J:60945
increased susceptibility to xenobiotic induced morbidity/mortality J:60945
increased white fat cell number J:118516
Cdkn1atm1Tyj/Cdkn1atm1Tyj
involves: 129S2/SvPas * C57BL/6 		abnormal CD4-positive, alpha beta T cell morphology J:60292
abnormal self tolerance J:60292
abnormal thymus physiology J:70894
decreased incidence of tumors by ionizing radiation induction J:70894
decreased mortality induced by ionizing radiation J:70894
decreased sensitivity to skin irradiation J:114161
enlarged cervical lymph nodes J:60292
enlarged lymph nodes J:60292
enlarged spleen J:60292
glomerulonephritis J:60292, J:70894
normal immune system phenotype J:60292
increased anti-double stranded DNA antibody level J:60292
increased anti-histone antibody level J:60292
increased anti-nuclear antigen antibody level J:60292
increased B cell derived lymphoma incidence J:70894
increased B cell number J:60292
increased carcinoma incidence J:70894
increased cellular sensitivity to gamma-irradiation J:70894
increased hemangiosarcoma incidence J:70894
increased histiocytic sarcoma incidence J:70894
increased IgG1 level J:60292
increased incidence of tumors by chemical induction J:80271
increased Leydig cell tumor incidence J:70894
increased lung carcinoma incidence J:70894
increased memory T cell number J:60292
increased sebaceous gland adenoma incidence J:70894
increased skin tumor incidence J:70894
increased spleen weight J:60292
increased T cell derived lymphoma incidence J:70894
increased T cell proliferation J:60292
increased tumor incidence J:70894
increased urinary system tumor incidence J:70894
increased urine protein level J:60292
kidney failure J:70894
lymph node hyperplasia J:60292
premature death J:60292, J:70894
spleen hyperplasia J:60292
Cdkn1atm2(HBx)Xya/Cdkn1a+
either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Cdkn1atm2(HBx)Xya/Cdkn1atm2(HBx)Xya
either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * Black Swiss) 		hepatic steatosis J:88078
increased hepatocellular carcinoma incidence J:88078
Tg(Ttr-Cdkn1a)36Tvd/?
B6.Cg-Tg(Ttr-Cdkn1a)36Tvd 		abnormal oval cell morphology J:94077
decreased body size J:94077
decreased hepatocyte proliferation J:94077
hyperglycemia J:94077
premature death J:94077
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory